PTC
ACAD icon

Private Trust Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Private Trust Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51
Closed -$847 – 2467
2025
Q1 		$847 Buy
+51
New +$926 ﹤0.01% 2381
2014
Q4 		– Sell
-40
Closed -$1K – 304
2014
Q3 		$1K Hold
40
– – ﹤0.01% 1695
2014
Q2 		$1K Sell
40
-8
-17% -$167 ﹤0.01% 1717
2014
Q1 		$1K Sell
48
-10
-17% -$253 ﹤0.01% 1596
2013
Q4 		$1K Hold
58
– – ﹤0.01% 1600
2013
Q3 		$2K Hold
58
– – ﹤0.01% 1382
2013
Q2 		$1K Buy
+58
New +$799 ﹤0.01% 1498

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return